1. Vision Engineering Italy srl, Rome, Italy;2. CNR‐IPCF, Istituto per i Processi Chimico‐Fisici, Messina, Italy;3. Opia Technologies SAS, Paris, France;4. Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal
Abstract:
Trans‐scleral iontophoresis device was shown to be effective for in‐situ delivery of lutein to the retina of human donor eyes. After treatment, Resonance Raman Spectroscopy measurements demonstrated that lutein greatly enriched the inner sclera, choroid and retina. Clinical studies are going to prove if the methodology would be a valuable approach to enrich the human macular pigment and prevent local oxidative damage in patients at risk of AMD progression. Further details can be found in the article by Marco Lombardo et al. ( e201700095 ).
